OPTISPAN
Live / Registered — Registered (as of 03 Dec 2024)
What this means for you
Registered since 03 Dec 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 03 Dec 2030: the §8 declaration of use).
Record
- Serial number
- 97694648
- Registration number
- 7590165
- Mark type
- Word mark
- Filed
- 28 Nov 2022
- Published for opposition
- 17 Oct 2023
- Registered
- 03 Dec 2024
- Next maintenance filing
- §8 declaration of use, due by 03 Dec 2030 (grace period to 03 Jun 2031)
- Attorney of record
- Kevin S. Costanza
Goods and services
- Class 042 — Scientific and technological services: Scientific research and development; pharmaceutical drug development services; testing of pharmaceuticals
Owner
- OPTISPAN, INC., SEATTLE, WA, US
- OPTISPAN, INC., SEATTLE, WA, US
- OPTISPAN GeroScience, LLC, Seattle, WA, US
- OPTISPAN GeroScience, LLC, Seattle, WA, US
Prosecution history
- 03 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
- 23 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Jul 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Jun 2024 — USE AMENDMENT FILED
- 19 Jul 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Jun 2024 — TEAS STATEMENT OF USE RECEIVED
- 07 Feb 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 Dec 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Oct 2023 — PUBLISHED FOR OPPOSITION
- 27 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Sept 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Sept 2023 — ASSIGNED TO EXAMINER